The announcement comes includes new dietary reference intakes for EPA and DHA, as well as special recommendations of DHA for certain populations.
The Chinese Nutrition Society has established dietary reference intakes (DRIs) for omega-3 fatty acids. That’s according to the Global Organization for EPA and DHA Omega-3s (GOED; Salt Lake City), which made the announcement in a recent members newsletter.
China’s DRI for EPA and DHA omegas is set at 250–2000 mg per day for adults, and that’s well above the 37 mg/day that one group of researchers estimates Chinese are currently ingesting. For special populations, China has even confirmed adequate intake (AI) levels for DHA. Children up to four years old are to consume 100 mg/day of DHA for an adequate intake, and pregnant and lactating women should consume 250 mg/day of EPA and DHA, with at least 200 mg of that being DHA.
GOED is petitioning China on specific omega-3 guidance for older children.
China’s announcement will be published in its “Handbook of Chinese DRIs 2013” along with many other new recommendations. The materials should be released in the coming months. And there’s still no word as to when the United States will publish its own omega-3 DRIs.
[Photo ©iStockphoto.com/Rixipix]
Robby Gardnerâ¨
Associate Editor
â¨Nutritional Outlook magazine
robby.gardner@ubm.com
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.